P2RX7 and neurodegenerative disease: Hence, the use of pharmacological inhibition as a therapeutic strategy seems interesting from the homeostasis point of view, considering that broad P2X7 receptor activation occurs mostly in inflammatory conditions, such as neurodegenerative diseases (Figure 2B).